Getting Unrestrained: Dr. Peter Rowe on Neuromuscular Strain in Chronic Fatigue Syndrome (ME/CFS)
Dr. Peter Rowe has been treating and studying young people with Chronic Fatigue Syndrome for over twenty years. Dr. Rowe was one of the first to validate the problem of orthostatic intolerance in ME/CFS. His recent publication on impaired...
Problems Standing? Studies Suggest Autoimmunity Causes Orthostatic Intolerance: Implications For Chronic Fatigue Syndrome
“In conclusion, these data support the addition of POTS to a growing number of cardiovascular entities with an autoimmune pathophysiology.” Authors The Rituximab findings, the female predominance, the increasing evidence of heritability, the inflammatory...
High Heart Rates and Low Blood Flows: the Visser Video Series on Chronic Fatigue Syndrome Continues
In the fifth web seminar produced by the ME/CFS Association in the Netherlands is by Dr. Visser, a Dutch cardiologist. He takes on Postural Orthostatic Tachycardia Syndrome (POTS). POTS refers to an overly rapid increase in the heart rate that occurs upon standing. ...
A Treatable Chronic Fatigue Syndrome Subset – If Doctors Will Just Look For It
Pretty Graphs Dr. Susan Vernon and Dr. Lucinda Bateman spoke in Denver on Saturday, June 28. Dr. Bateman gave a presentation on research out of the University of Utah she co-authored in her talk, “Treatment Options for ME/CFS and Fibromyalgia patients I took...The Splitter: Researcher Asserts ‘Brain-damaged’ Subset Present in Chronic Fatigue Syndrome (ME/CFS)
The Subset Researcher Virtually everybody for decades has believed ME/CFS is larded with subsets and everyone agrees we must find them yet very few researchers, through lack of money or initiative, have actually looked for them in an organized fashion. Dr. Natelson...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
